Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2826_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •Preface
- •Malignant disease
- •Rheumatology
- •Water and electrolytes
- •Renal disease
- •Cardiovascular disease
- •Respiratory disease
- •Intensive care medicine
- •Poisoning, drug and alcohol abuse
- •Endocrinology
- •Diabetes mellitus and other disorders of metabolism
- •The special senses
- •Neurology
- •Dermatology
- •Elderly medicine and frailty
- •Abbreviations
- •Medical emergencies
- •Symptom Based
- •System Based
- •Infectious diseases and tropical medicine
- •Gastroenterology and nutrition
- •Liver, biliary tract and pancreatic disease
- •Diseases of the blood and haematological malignancies
- •Significant websites
- •Guidelines and evidence-based medicine
- •Medical calculators
- •Chapter-specific websites
- •Legally Valid Consent
- •Capacity
- •Information disclosure
- •Obtaining consent
- •Special circumstances
- •Adults who lack capacity to consent
- •Advance decisions
- •Children
- •Teaching
- •Human immunodeficiency virus testing
- •End-of-life decisions including assisted dying
- •Cardiopulmonary resuscitation
- •Confidentiality
- •Communication
- •The medical interview
- •1. Building a relationship
- •2. Opening the discussion
- •3. Gathering information
- •4. Understanding the patient
- •5. Sharing information
- •6. Reaching agreement on management
- •7. Providing closing
- •Breaking bad news
- •Communication in difficult circumstances
- •When things go wrong
- •Complaints
- •Culture and communication
- •Patients with impaired faculties for communication
- •Medical record keeping
- •Team communication
- •2 Infectious diseases
- •Common investigations in infectious disease
- •Septicaemia
- •Pyrexia of unknown origin
- •Investigations
- •Management
- •Common Viral Infections
- •Clinical features
- •Complications
- •Management
- •Clinical features
- •Management
- •Diagnosis
- •Management
- •Herpes viruses
- •Herpes simplex virus (HSV)
- •Investigations
- •Management
- •Varicella zoster virus
- •Varicella (chickenpox)
- •Herpes zoster (shingles)
- •Epstein–Barr virus infection
- •Clinical features
- •Investigations
- •Management
- •Bacterial Infections
- •Lyme disease
- •Clinical features
- •Investigations
- •Management
- •Clinical features
- •Investigations
- •Management
- •Rickettsia
- •Management
- •Treatment of uncomplicated falciparum malaria
- •Prevention and control
- •Clinical features
- •Investigations
- •Management and prevention
- •Enterocolitis
- •Dengue fever
- •Schistosomiasis
- •Fever in the Returned Traveller
- •Approach to diagnosis
- •Investigations
- •Aetiology
- •Pathogenesis
- •Clinical features
- •Investigations
- •Miscellaneous Viral Infections
- •Zika
- •MERS Co-V
- •Clostridium difficile
- •Pathology and clinical features
- •Management
- •Prevention of C. difficile infection
- •Travellers’ diarrhoea
- •Clinical features
- •Treatment and prevention
- •Clinical features
- •Intestinal amoebiasis (amoebic dysentery)
- •Amoebic liver abscess
- •Investigations
- •Serology
- •Colonic disease
- •Liver disease
- •Differential diagnosis
- •Management
- •Pathophysiology and clinical features
- •Management
- •Prevention and control
- •Giardiasis
- •Clinical features
- •Investigations
- •Management
- •Helminthic Infections
- •Sexually Transmitted Infections
- •Gonorrhoea
- •Clinical features
- •Diagnosis
- •Management
- •Chlamydia urethritis
- •Genital ulcers
- •Syphilis
- •Early stages
- •Primary infection
- •Secondary infection
- •Late stages
- •Tertiary syphilis
- •Congenital syphilis
- •Treponemal tests.
- •Non-treponemal tests.
- •Diagnosis
- •Management
- •Routes of acquisition
- •Pathogenesis of HIV infection
- •Natural history of HIV infection
- •Clinical features
- •Diagnosis
- •Human Immuodeficiency Virus
- •Monitoring
- •Management
- •Conditions due to immunodeficiency
- •Fungi
- •Protozoal infections
- •Viruses
- •Bacterial infection
- •Neoplasia
- •Prevention and control
- •Prognosis
- •Therapeutics
- •Antibacterials
- •β-Lactam antibacterials
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •Cephalosporins
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •Aminoglycosides
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •Macrolides
- •Mechanism of action
- •Indications
- •Side effects
- •Metronidazole
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •Quinolones
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •Gastroenterology
- •Symptoms of Gastrointestinal Disease
- •Dyspepsia and indigestion
- •Dysphagia
- •Vomiting
- •Flatulence
- •Diarrhoea and constipation
- •Steatorrhoea
- •Abdominal pain
- •Investigation of Gastrointestinal Disease
- •Endoscopy
- •Oesophagogastroduodenoscopy (OGD, ‘gastroscopy’)
- •Sigmoidoscopy
- •Colonoscopy
- •Imaging
- •Plain X-rays
- •Ultrasound
- •Computed tomography (CT) scan
- •Magnetic resonance imaging (MRI)
- •Positron emission tomography (PET)
- •Contrast studies
- •Oesophageal physiology testing
- •The Mouth
- •Mouth ulcers
- •Non-infective
- •Infective
- •Oral white patches
- •The tongue
- •Periodontal disorders
- •Salivary gland disorders
- •The Oesophagus
- •Symptoms of oesophageal disorders
- •Gastro-oesophageal reflux disease (GORD)
- •Pathophysiology
- •Clinical features
- •Investigations
- •Management
- •Complications
- •Peptic stricture
- •Barrett’s oesophagus
- •Achalasia
- •Clinical features
- •Investigations
- •Management
- •Complications
- •Systemic sclerosis
- •Other oesophageal dysmotility disorders
- •Hiatus hernia
- •Benign oesophageal strictures
- •Oesophageal infection
- •Eosinophilic oesophagitis
- •Oesophageal perforation
- •Malignant oesophageal tumours
- •Pathology
- •Epidemiology and aetiological factors
- •Clinical features
- •Investigations
- •Management
- •Prognosis
- •Benign oesophageal tumours
- •The Stomach and Duodenum
- •Helicobacter pylori infection
- •Epidemiology
- •Clinicopathological features
- •Diagnosis of infection
- •Management
- •Peptic ulcer disease
- •Epidemiology
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Complications
- •Management of dyspepsia
- •Gastropathy
- •Gastritis
- •Gastric cancer
- •Epidemiology
- •Aetiology
- •Pathology
- •Clinical features
- •Investigations
- •Management
- •Prognosis
- •Other gastric tumours
- •Gastrointestinal Bleeding
- •Acute upper gastrointestinal bleeding
- •Aetiology
- •Management
- •Endoscopy
- •Post-endoscopy
- •Lower gastrointestinal bleeding
- •Management
- •Chronic gastrointestinal bleeding
- •Investigations
- •Management
- •The Small Intestine
- •Coeliac disease (gluten-sensitive enteropathy)
- •Aetiology
- •Clinical features
- •Investigations
- •Other investigations
- •Management
- •Complications
- •Dermatitis herpetiformis
- •Tropical sprue
- •Bacterial overgrowth
- •Clinical features
- •Diagnosis
- •Management
- •Intestinal resection
- •Whipple’s disease
- •Miscellaneous Small Intestinal Conditions
- •Tuberculosis
- •Clinical features
- •Diagnosis
- •Management
- •Protein-losing enteropathy
- •Meckel’s diverticulum
- •Intestinal ischaemia
- •Tumours of the small intestine
- •Malignant tumours
- •Benign small bowel tumours
- •Carcinoid tumours
- •Pathology
- •Clinical features
- •Investigations
- •Management
- •Epidemiology
- •Aetiology
- •Genetic susceptibility
- •Environment
- •Inflammatory Bowel Disease
- •Host immune response
- •Pathology
- •Clinical features
- •Crohn’s disease
- •Ulcerative colitis
- •Radiology and imaging
- •Investigations
- •Differential diagnosis
- •Management
- •Medical
- •Induction of remission
- •Maintenance of remission
- •Surgery
- •Cancer in inflammatory bowel disease
- •Prognosis
- •Microscopic colitis
- •The Colon and Rectum
- •Constipation
- •Investigation
- •Management
- •Faecal incontinence
- •Diverticular disease
- •Aetiology
- •Clinical features
- •Management
- •Miscellaneous conditions
- •Megacolon
- •Ischaemic colitis
- •Adenomatous polyps
- •Colon polyps and the polyposis syndromes
- •Colorectal cancer
- •Epidemiology
- •Inheritance
- •Pathology
- •Clinical features
- •Investigation
- •Management
- •Prognosis
- •Screening
- •Diarrhoea
- •Mechanisms of diarrhoea
- •Osmotic diarrhoea
- •Secretory diarrhoea
- •Inflammatory diarrhoea (mucosal destruction)
- •Motility related
- •Approach to the patient with diarrhoea
- •Investigation
- •History
- •Examination
- •Investigations
- •Functional Bowel Disorders
- •The Acute Abdomen
- •Acute appendicitis
- •Epidemiology
- •Clinical features
- •Investigations
- •Differential diagnosis
- •Management
- •Complications
- •Acute peritonitis
- •Intestinal obstruction
- •The Peritoneum
- •Nutrition
- •Dietary requirements
- •Nutritional Support
- •Enteral nutrition
- •Total parenteral nutrition (TPN)
- •Monitoring of artificial nutrition
- •Refeeding syndrome
- •Disorders of BODY WEIGHT
- •Obesity
- •Anorexia nervosa
- •Therapeutics
- •Drugs for dyspepsia and peptic ulceration
- •Antacids
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •H2-receptor antagonists
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •Proton pump inhibitors
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •Constipation
- •Bulk-forming laxatives
- •Mechanism of action
- •Indications
- •Preparations and dose
- •Side effects
- •Cautions/contraindications
- •Stimulant laxatives
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •Osmotic laxatives
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •Bowel-cleansing solutions
- •Indications
- •Side effects
- •Diarrhoea
- •Side effects
- •Cautions/contraindications
- •Nausea and vomiting
- •Antihistamines
- •Indications
- •Mechanism of action
- •Side effects
- •Cautions/contraindications
- •Phenothiazines
- •Mechanism of action
- •Indications
- •Side effects
- •Domperidone and metoclopramide
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •5-HT3-receptor antagonists
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •Liver Biochemistry and Liver Function Tests
- •Other Investigations in Liver and Biliary Disease
- •Symptoms and Signs of Liver Disease
- •Jaundice
- •Haemolytic jaundice
- •Congenital hyperbilirubinaemia
- •Cholestatic jaundice
- •Investigations
- •Hepatitis
- •Viral hepatitis
- •Hepatitis A
- •Epidemiology
- •Clinical features
- •Investigations
- •Differential diagnosis
- •Management
- •Prophylaxis
- •Hepatitis B
- •Epidemiology
- •Viral structure
- •Acute HBV infection
- •Chronic HBV infection
- •Treatment of chronic infection: who to treat
- •Antiviral agents
- •Hepatitis B and HIV co-infection
- •Prophylaxis
- •Hepatitis D (delta or δ agent)
- •Hepatitis C
- •Hepatitis C virus
- •Chronic hepatitis C infection
- •Hepatitis E
- •Acute hepatic failure
- •Alcohol use
- •Screening for problem drinking
- •Consequences of alcohol use and dependence
- •Autoimmune hepatitis
- •Aetiology
- •Clinical features
- •Investigations
- •Treatment
- •Prognosis
- •Aetiology
- •Pathology
- •Clinical features
- •Non-Alcoholic Fatty Liver Disease
- •Cirrhosis
- •Investigations
- •Severity
- •Aetiology
- •Further investigations
- •Management
- •Prognosis
- •Portal hypertension
- •Aetiology
- •Clinical features
- •Variceal haemorrhage
- •Management
- •Ascites
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Complications
- •Portosystemic encephalopathy
- •Pathophysiology
- •Clinical features
- •Differential diagnosis
- •Investigations
- •Management
- •Hepatorenal syndrome
- •Hepatopulmonary syndrome
- •Liver Transplantation
- •Types of Chronic Liver Disease and Cirrhosis
- •Alcoholic cirrhosis
- •Primary biliary cholangitis
- •Epidemiology
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Prognosis
- •Secondary biliary cirrhosis
- •Hereditary haemochromatosis
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Prognosis
- •Wilson’s disease (hepatolenticular degeneration)
- •α1-Antitrypsin deficiency
- •Alcohol and the liver
- •Fatty change
- •Alcoholic hepatitis
- •Clinical features
- •Investigations
- •Management
- •Alcoholic cirrhosis
- •Aetiology
- •Clinical features
- •Investigations
- •Treatment
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Primary Sclerosing Cholangitis
- •Budd–Chiari Syndrome
- •Liver Abscess
- •Liver Disease in Pregnancy
- •Liver Tumours
- •Hepatocellular carcinoma (hepatoma)
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Prognosis
- •Benign liver tumours
- •Pathophysiology
- •Clinical presentation
- •Gallstones
- •Biliary pain
- •Clinical features
- •Investigations
- •Management
- •Acute cholecystitis
- •Clinical features
- •Investigations
- •Management
- •Chronic cholecystitis
- •Acute cholangitis
- •Clinical features
- •Investigations
- •Management
- •Common bile duct stones (choledocholithiasis)
- •The Pancreas
- •Pancreatitis
- •Acute pancreatitis
- •Pathogenesis
- •Clinical features
- •Investigation
- •Management
- •General supportive care
- •Complications
- •Chronic pancreatitis
- •Clinical features
- •Investigations
- •Treatment
- •Epidemiology
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Prognosis
- •Carcinoma of the Pancreas
- •Cancer of the bile ducts
- •Neuroendocrine Tumours of the Pancreas
- •5 Haematological disease
- •Anaemia
- •Microcytic anaemia
- •Iron deficiency
- •Causes of iron deficiency
- •Clinical features
- •Investigations
- •Differential diagnosis
- •Management
- •Anaemia of chronic disease
- •Sideroblastic anaemia
- •Macrocytic anaemia
- •Megaloblastic anaemia
- •Vitamin B12 deficiency
- •Pernicious anaemia
- •Epidemiology
- •Clinical features
- •Investigation of vitamin B12 deficiency
- •Differential diagnosis
- •Management
- •Folate deficiency
- •Clinical features
- •Investigations
- •Management
- •Prevention of neural tube defects with folic acid.
- •Differential diagnosis
- •Anaemia caused by marrow failure (aplastic anaemia)
- •Aetiology
- •Clinical features
- •Investigations
- •Differential diagnosis
- •Management
- •Haemolytic Anaemia
- •Inherited Haemolytic Anaemias
- •Membrane defects
- •Hereditary spherocytosis
- •Clinical features
- •Investigations
- •Management
- •Hereditary elliptocytosis
- •Haemoglobin abnormalities
- •Thalassaemia
- •β-Thalassaemia
- •Investigations
- •Management
- •α-Thalassaemia
- •Sickle syndromes
- •Sickle cell anaemia
- •Clinical features
- •Vaso-occlusion.
- •Anaemia.
- •Long-term problems.
- •Investigations
- •Management
- •Red cell concentrates.
- •Platelet concentrates
- •Sickle cell trait
- •Metabolic red cell disorders
- •Glucose-6-phosphate dehydrogenase deficiency
- •Acquired Haemolytic Anaemia
- •Autoimmune haemolytic anaemia
- •‘Warm’ autoimmune haemolytic anaemia
- •Clinical features
- •Investigation
- •Management
- •‘Cold’ autoimmune haemolytic anaemia
- •Clinical features
- •Investigation
- •Management
- •Drug-induced haemolysis
- •Non-immune haemolytic anaemia
- •Paroxysmal nocturnal haemoglobinuria
- •Mechanical haemolytic anaemia
- •Myeloproliferative Disorders
- •Polycythaemia
- •Polycythaemia vera
- •Clinical features
- •Investigations
- •Management
- •Secondary polycythaemia
- •Essential thrombocythaemia
- •Myelofibrosis (myelosclerosis)
- •Clinical features
- •Investigations
- •Management
- •Myelodysplasia
- •The Spleen
- •Splenomegaly
- •Blood Transfusion
- •Fresh frozen plasma
- •Cryoprecipitate
- •Factor VIII and IX concentrates
- •Albumin
- •Immunoglobulins
- •Neutrophil leucocytosis
- •Neutropenia
- •Vascular/platelet bleeding
- •Coagulation disorders
- •Blood groups
- •Procedure for blood transfusion
- •Complications of transfusing red blood cells
- •The White Cell
- •Neutrophils
- •Eosinophils
- •Monocytes
- •Lymphocytes
- •Haemostasis and Thrombosis
- •Haemostasis
- •Investigation of bleeding disorders
- •Platelet disorders
- •Immune thrombocytopenic purpura (ITP)
- •Investigation
- •Management
- •First-line therapy.
- •Second-line therapy
- •Thrombotic thrombocytopenic purpura (TTP)
- •Inherited coagulation disorders
- •Haemophilia A
- •Clinical features
- •Investigations
- •Management
- •Complications
- •Haemophilia B (Christmas disease)
- •von Willebrand’s disease
- •Clinical features
- •Investigations
- •Management
- •Acquired coagulation disorders
- •Vitamin K deficiency
- •Disseminated intravascular coagulation (DIC)
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Liver disease
- •Thrombosis
- •Arterial thrombosis
- •Prevention
- •Treatment
- •Venous thrombosis
- •Prevention
- •Treatment
- •Treatment of established thromboembolism
- •Ferrous sulphate.
- •Folic acid.
- •Hydroxocobalamin.
- •Cyanocobalamin.
- •Phytomenadione.
- •Menadiol sodium phosphate
- •Aspirin.
- •Clopidogrel.
- •Therapeutics
- •Oral iron
- •Indications
- •Preparations and dose
- •Side effects
- •Cautions/contraindications
- •Folic acid
- •Indications
- •Preparations and dose
- •Side effects
- •Cautions/contraindications
- •Indications
- •Preparations and dose
- •Side effects
- •Cautions/contraindications
- •Vitamin K
- •Mechanism of action
- •Indications
- •Preparations and dose
- •Side effects
- •Cautions/contraindications
- •Drugs affecting haemostasis
- •Antiplatelet agents
- •Mechanism of action
- •Indications
- •Side effects
- •Cautions/contraindications
- •Thrombin inhibitors
- •Mechanism of action
- •Indications
- •Warfarin.
- •Drug interactions.
- •Alteplase.
- •Side effects
- •Cautions/contraindications
- •Oral anticoagulants
- •Mechanism of action
- •Indications
- •Preparations and dose
- •Side effects
- •Contraindications
- •Direct oral anticoagulants (DOACs)
- •Mechanism of action
- •Preparations and indications
- •Side effects
- •Contraindications
- •Fibrinolytic drugs
- •Mechanism of action
- •Indications
- •Preparations and dose
- •Side effects
- •Contraindications
- •6 Malignant disease
- •Diagnosis of Malignancy
- •Cancer treatment
- •Chemotherapy
- •Radiotherapy
- •Endocrine therapy
- •Biological therapy
- •Myeloablative Therapy and Haemopoietic Stem Cell Transplantation (HSCT)
- •Oncological emergencies
- •The leukaemias
- •Aetiology
- •Acute leukaemia
- •Epidemiology
- •Clinical features
- •Investigations
- •Management
- •Treatment
- •Acute myeloid leukaemia
- •Acute promyelocytic leukaemia
- •Acute lymphoblastic leukaemia
- •Chronic myeloid leukaemia
- •Clinical features
- •Investigations
- •Management
- •Chronic lymphocytic leukaemia
- •Clinical features
- •Investigations
- •Management
- •Prognosis
- •The Lymphomas
- •Hodgkin’s lymphoma
- •Clinical features
- •Investigations
- •Differential diagnosis
- •Management
- •Non-Hodgkin’s lymphoma
- •Clinical features
- •Investigations
- •Management
- •The Paraproteinaemias
- •Multiple myeloma
- •Clinical features
- •Investigations
- •Management
- •Monoclonal gammopathy of undetermined significance
- •Management of pain
- •Palliation of nausea and vomiting
- •Care of the dying patient
- •Palliative Medicine and Symptom Control
- •7 Rheumatology
- •The Normal Joint
- •Musculoskeletal Symptoms
- •Common Investigations in Musculoskeletal Disease
- •Blood tests
- •Imaging
- •Synovial fluid analysis
- •Common Regional Musculoskeletal Problems
- •Back Pain
- •Lumbar back pain
- •Investigations
- •Management
- •Intervertebral Disc Disease
- •Acute disc disease
- •Clinical features
- •Investigations
- •Management
- •Chronic disc disease
- •Mechanical problems
- •Spondylolisthesis
- •Spinal stenosis
- •Neck pain
- •Epidemiology
- •Pathology and pathogenesis
- •Clinical features
- •Differential diagnosis
- •Investigations
- •Management
- •Osteoarthritis
- •Inflammatory Arthritis
- •Rheumatoid arthritis
- •Epidemiology
- •Aetiology and pathogenesis
- •Pathology
- •Clinical features
- •Non-articular manifestations
- •Investigations
- •Differential diagnosis
- •Management
- •Prognosis
- •The Seronegative Spondyloarthritis
- •Axial spondylarthritis
- •Clinical features
- •Investigations
- •Management
- •Psoriatic arthritis
- •Clinical features
- •Investigations
- •Treatment
- •Reactive arthritis
- •Clinical features
- •Investigations
- •Management
- •Enteropathic arthritis
- •Crystal Arthritis
- •Gout and hyperuricaemia
- •Epidemiology
- •Pathogenesis
- •Clinical features
- •Investigations
- •Management
- •Pseudogout (pyrophosphate arthropathy)
- •Investigations
- •Management
- •Infection of Bones and Joints
- •Septic arthritis
- •Clinical features
- •Management
- •Specific types of bacterial arthritis
- •Osteomyelitis
- •Autoimmune Rheumatic Diseases
- •Systemic lupus erythematosus
- •Epidemiology
- •Aetiology
- •Pathogenesis
- •Clinical features
- •Investigations
- •Management
- •Prognosis
- •Antiphospholipid syndrome
- •Clinical features
- •Management
- •Systemic sclerosis (scleroderma)
- •Aetiology
- •Clinical features
- •Limited cutaneous scleroderma (LcSSc, 70% of cases)
- •Diffuse cutaneous scleroderma (DcSSc, 30% of cases)
- •Investigations
- •Management
- •Prognosis
- •Polymyositis and dermatomyositis
- •Clinical features
- •Investigations
- •Management
- •Sjögren’s syndrome
- •Clinical features
- •Investigations
- •Management
- •‘Overlap’ syndrome and undifferentiated autoimmune rheumatic disease
- •Systemic Inflammatory Vasculitis
- •Polymyalgia rheumatica and giant cell arteritis
- •Clinical features
- •Investigations
- •Management
- •Takayasu’s arteritis
- •Polyarteritis nodosa
- •Kawasaki disease
- •Microscopic polyarteritis (polyangiitis)
- •Eosinophilic granulomatosis with polyangiitis
- •Henoch–Schönlein purpura
- •Cryoglobulinaemic vasculitis
- •Behçet’s disease
- •Diseases of Bone
- •Control of calcium and bone metabolism
- •Vitamin D
- •Parathyroid hormone
- •Osteoporosis
- •Aetiology
- •Clinical features
- •Investigations
- •Assessment of fracture risk
- •Management
- •Clinical features
- •Investigations
- •Treatment
- •Osteomalacia and vitamin D deficiency
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Therapeutics
- •Anti-inflammatories and pain relief
- •Paracetamol (acetaminophen)
- •Non-steroidal anti-inflammatory drugs
- •Mechanism of action
- •Indications
- •Examples of preparations and doses
- •Side effects
- •Gastrointestinal toxicity.
- •Other side effects
- •Cautions/contraindications
- •Drugs affecting bone metabolism
- •Bisphosphonates
- •Mechanism of action
- •Indications
- •Examples of preparations and doses
- •Side effects
- •Calcium
- •Indications
- •Examples of preparations and doses
- •Side effects
- •Vitamin D
- •Mechanism of action
- •Indications
- •Examples of preparations and doses
- •Side effects
- •Water and Electrolyte Requirements
- •Body Fluid Compartments
- •Distribution of extracellular fluid
- •Glucocorticoid-induced osteoporosis
- •Osteonecrosis
- •Paget’s disease
- •Aetiology
- •Intravenous fluids in clinical practice
- •Regulation of Body Fluid Homeostasis
- •Regulation of extracellular volume
- •Abnormalities of extracellular volume
- •Increased extracellular volume
- •Clinical features
- •Aetiology
- •Management
- •Decreased extracellular volume
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Plasma Osmolality and Disorders of Sodium Regulation
- •Regulation of body water content
- •Hyponatraemia
- •Hyponatraemia resulting from salt loss (hypovolaemic hyponatraemia)
- •Clinical features
- •Management
- •Hyponatraemia resulting from water excess (dilutional hyponatraemia)
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Central pontine myelinolysis
- •Hypernatraemia
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Disorders of Potassium Regulation
- •Hypokalaemia
- •Aetiology
- •Clinical features
- •Management
- •Hyperkalaemia
- •Aetiology
- •Clinical features
- •Management
- •Disorders of Magnesium Regulation
- •Hypomagnesaemia
- •Aetiology
- •Clinical features
- •Management
- •Hypermagnesaemia
- •Disorders of Acid–Base Balance
- •Respiratory acidosis
- •Respiratory alkalosis
- •Metabolic acidosis
- •Clinical features
- •Differential diagnosis (the anion gap)
- •Lactic acidosis
- •Diabetic ketoacidosis
- •Renal tubular acidosis
- •Uraemic acidosis
- •Metabolic alkalosis
- •Clinical features
- •Management
- •Therapeutics
- •Diuretics
- •Thiazide diuretics
- •Examples
- •Mechanism of action
- •Indications
- •Side effects
- •Loop diuretics
- •Examples
- •Mechanism of action
- •Indications
- •Side effects
- •Potassium-sparing diuretics and aldosterone antagonists
- •Examples
- •Mechanism of action
- •Indications
- •Side effects
- •9 Renal disease
- •Presenting Features Of Renal Disease
- •Dysuria
- •Polyuria and nocturia
- •Oliguria
- •Haematuria
- •Pain
- •Investigation Of Renal Disease
- •Blood tests
- •Glomerular filtration rate
- •Urine dipstick testing
- •Proteinuria
- •Haematuria
- •Glycosuria
- •Urine microscopy
- •White cells
- •Red cells
- •Casts
- •Bacteria
- •Imaging techniques
- •Transcutaneous renal biopsy
- •Glomerular Diseases
- •Normal glomerular structure
- •Pathogenesis and terms in glomerular disease
- •Classification and presentation of glomerulopathies
- •Aetiology
- •Nephrotic syndrome with ‘bland’ urine sediments
- •Nephrotic syndrome with ‘active’ urine sediments (mixed nephrotic/nephritic)
- •Clinical features
- •Differential diagnoses
- •Investigations
- •Management
- •General oedema
- •Specific treatment
- •Complications
- •Nephrotic Syndrome
- •Acute glomerulonephritis (acute nephritic syndrome)
- •Clinical features
- •Investigations
- •Management
- •Rapidly progressive glomerulonephritis
- •Urinary Tract Infection
- •Pathogenesis
- •Risk factors for UTI
- •Clinical features
- •Natural history
- •Investigations
- •Diagnosis
- •Treatment of single isolated attack
- •Recurrent infection.
- •Management
- •UTI in pregnancy
- •Abacteriuric frequency or dysuria (‘urethral syndrome’)
- •Bacterial prostatitis
- •Tuberculosis of the urinary tract
- •Tubulointerstitial Nephritis
- •Acute tubulointerstitial nephritis
- •Chronic tubulointerstitial nephritis
- •Hypertension and the Kidney
- •Essential hypertension
- •Renal hypertension
- •Bilateral renal disease
- •Renovascular disease
- •Options for renal artery imaging
- •Management
- •Aetiology
- •Calcium stones
- •Uric acid stones
- •Infection-induced stones
- •Cystine stones
- •Clinical features
- •Differential diagnosis
- •Investigations
- •Management
- •Renal Calculi and Nephrocalcinosis
- •Nephrocalcinosis
- •Aetiology
- •Clinical features
- •Investigations
- •Management
- •Epidemiology
- •Clinical and biochemical features
- •Urinary Tract Obstruction
- •Acute Kidney Injury
- •Investigation of the uraemic emergency
- •Investigations
- •Management
- •Prognosis
- •Aetiology
- •Chronic Kidney Disease
- •Clinical features and investigations
- •Differentiating AKI from CKD
- •Management
- •Renoprotection
- •Reduce cardiovascular risk
- •Correction of complications
- •Referral to a nephrologist
- •Renal Replacement Therapy
- •Dialysis
- •Haemodialysis
- •Peritoneal dialysis
- •Haemofiltration
- •Complications of all long-term dialysis
- •Transplantation
- •Cystic Renal Disease
- •Solitary and multiple renal cysts
- •Autosomal-dominant polycystic kidney disease
- •Clinical features
- •Diagnosis
- •Management
- •Medullary sponge kidney
- •Tumours of the Kidney and Genitourinary Tract
- •Renal cell carcinoma
- •Clinical features
- •Investigations
- •Management
- •Prognosis
- •Urothelial tumours
- •Clinical features
- •Investigations
- •Management
- •Diseases Of The Prostate Gland
- •Benign enlargement of the prostate gland
- •Clinical features
- •Investigations
- •Management
- •Prostatic carcinoma
- •Clinical features
- •Investigation
- •Management
- •Screening
- •Clinical features
- •Investigations
- •Treatment
- •Testicular Tumour
- •Urinary Incontinence
- •Normal bladder physiology
- •Stress incontinence
- •Urge incontinence
- •Overflow incontinence
- •Neurological causes
- •Chest pain
- •Dyspnoea
- •Palpitations
- •Syncope
- •Other symptoms
- •Investigations in Cardiac Disease
- •The chest X-ray
- •ECG waveform and definitions (Fig. 10.5)
- •The Electrocardiogram
- •Exercise electrocardiography
- •24-hour ambulatory taped electrocardiography
- •Tilt testing
- •Echocardiography
- •Cardiac nuclear imaging
- •Cardiac computed tomography
- •Cardiovascular magnetic resonance
- •Positron emission tomography
- •Cardiac catheterization
- •Cardiac Arrhythmias
- •General principles of management of arrhythmias
- •Sinus rhythms
- •Sinus arrhythmia
- •Bradycardias and heart block
- •Sinus bradycardia
- •Neurally mediated syndromes
- •Heart block
- •Atrioventricular block
- •Bundle branch block
- •Supraventricular tachycardias
- •Sinus tachycardia
- •Atrioventricular junctional tachycardias
- •Atrioventricular nodal re-entry tachycardia (AVNRT)
- •Atrioventricular reciprocating tachycardia (AVRT)
- •Symptoms
- •Acute management
- •Long-term management
- •Atrial tachyarrhythmias
- •Atrial fibrillation
- •Management
- •Assessment for anticoagulation
- •Atrial flutter
- •Ventricular tachyarrhythmias
- •Ventricular ectopic premature beats (extrasystoles)
- •Sustained ventricular tachycardia
- •Non-sustained ventricular tachycardia
- •Ventricular fibrillation
- •Long QT syndrome
- •Cardiac arrest
- •Aetiology
- •Pathophysiology
- •Venous return (preload)
- •Outflow resistance (afterload)
- •Myocardial contractility
- •Neurohormonal and sympathetic system activation: salt and water retention
- •Natriuretic peptides
- •Antidiuretic hormone (vasopressin)
- •Clinical features
- •Symptoms
- •Signs
- •Investigations
- •Treatment of chronic heart failure
- •Heart Failure
- •Drug treatment
- •Non-pharmacological treatment
- •Acute heart failure
- •Clinical features
- •Management
- •Irreversible risk factors for coronary artery disease
- •Potentially changeable risk factors
- •Estimation of cardiovascular risk
- •Ischaemic Heart Disease
- •Angina
- •Clinical features
- •Diagnosis
- •Investigations
- •Management
- •Acute coronary syndromes
- •Clinical features
- •Treatment of NSTEMI and unstable angina
- •Risk stratification
- •ST segment elevation myocardial infarction (STEMI)
- •Clinical features
- •Investigations
- •Management
- •Complications (Table 10.10)
- •Disturbances of rate, rhythm and conduction (p. 411)
- •Post-ACS drug therapy and assessment
- •Epidemiology
- •Clinical features
- •Investigations
- •Treatment
- •Rheumatic Fever
- •Chronic rheumatic heart disease
- •Valvular Heart Disease
- •Prosthetic heart valves
- •Mitral stenosis
- •Aetiology
- •Pathophysiology
- •Symptoms
- •Signs
- •Investigations
- •Management
- •Mitral regurgitation
- •Aetiology
- •Pathophysiology
- •Symptoms
- •Signs
- •Investigations
- •Management
- •Prolapsing (‘floppy’) mitral valve
- •Aetiology
- •Clinical features
- •Investigation
- •Management
- •Aortic stenosis
- •Aetiology
- •Pathophysiology
- •Symptoms
- •Signs
- •Investigations
- •Management
- •Aortic regurgitation
- •Aetiology
- •Pathophysiology
- •Symptoms
- •Signs
- •Investigations
- •Management
- •Tricuspid and pulmonary valve disease
- •Infective endocarditis
- •Aetiology
- •Pathology
- •Clinical features
- •Investigations
- •Diagnostic criteria
- •Management
- •Surgery
- •Pulmonary Heart Disease
- •Pulmonary hypertension
- •Aetiology

The Electrocardiogram 403
(A)
(B)
V
6
V
V
V
1
V
2
3
5
V
4
RA
LA
LV
RV
V
3
V
V
2
1
V
6
V
5
V
4
Fig. 10.3 ECG chest leads. (A) The V leads are attached to the chest wall
overlying the intercostal spaces as shown: V4 in the mid-clavicular line, V5 in the
anterior axillary line, V6 in the mid-axillary line. (B) Leads V1 and V2 look at the
right ventricle, V3 and V4 at the interventricular septum, and V5 and V6 at the left
ventricle. The normal QRS complex in each lead is shown. The R wave in the
chest (precordial) leads steadily increases in amplitude from lead V1 to V6 with a
corresponding decrease in S wave depth, culminating in a predominantly positive
complex in V6. LA, left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle.
Left ventricular hypertrophy with increased bulk of the left ventricular
myocardium (e.g. with systemic hypertension) increases the voltage-induced
depolarization of the free wall of the left ventricle. This gives rise to tall R
waves (>25 mm) in the left ventricular leads (V5, V6) and/or deep S waves
(>30 mm) in the right ventricular leads (V1, V2). The sum of the R wave

404 Cardiovascular disease
The bipolar leads The augmented unipolar leads
I
AVR
AVL
III
II
AVF
Fig. 10.4 ECG limb leads. Lead I is derived from electrodes on the right arm
(negative pole) and left arm (positive pole), lead II is derived from electrodes
on the right arm (negative pole) and left leg (positive pole) and lead III from
electrodes on the left arm (negative pole) and the left leg (positive pole).
in the left ventricular leads and the S wave in the right ventricular leads
exceeds 40 mm. In addition to these changes, there may also be ST-segment
depression and T-wave flattening or inversion in the left ventricular leads.
Right ventricular hypertrophy (e.g. in pulmonary hypertension) causes tall
R waves in the right ventricular leads.
The QRS duration reflects the time that excitation takes to spread
through the ventricle. A wide QRS complex (>0.10 s, 2.5 small squares)
occurs if conduction is delayed, e.g. with right or left bundle branch block,
or if conduction is through a pathway other than the right and left bundle
branches, e.g. an impulse generated by an abnormal focus of activity in the
ventricle (ventricular ectopic).
T waves result from ventricular repolarization. In general the direction of
the T wave is the same as that of the QRS complex. Inverted T waves occur
in many conditions and, although usually abnormal, they are a non-specific
finding.

The Electrocardiogram 405
Voltage (mV)
10 mm = 1 mV
R
ST segment
T
Isoelectric line
PR
interval
P
QS
QRS interval
QT interval
1 mm
0 0.2 0.4 0.6 0.8
Time (s)
Fig. 10.5 The waves and elaboration of the normal electrocardiogram.
The PR interval is measured from the start of the P wave to the start of
the QRS complex whether this is a Q wave or an R wave. It is the time taken
for excitation to pass from the sinus node, through the atrium, atrioventricular
node and His-Purkinje system to the ventricle. A prolonged PR interval
(>0.2 s) indicates heart block (p. 412).
The ST segment is the period between the end of the QRS complex
and the start of the T wave. ST elevation (>1 mm above the isoelectric
line) occurs in the early stages of MI (p. 444) and with acute pericarditis
(p. 449). ST segment depression (>0.5 mm below the isoelectric line)
indicates myocardial ischaemia.
The QT interval extends from the start of the QRS complex to the end of
the T wave. It is primarily a measure of the time taken for repolarization of the
ventricular myocardium, which is dependent on heart rate (shorter at faster
heart rates). The QT interval, corrected for heart rate (QTc = QT/√2(R − R)),
is normally ≤0.44 s in males and ≤0.46 s in females. Long QT syndrome
(p. 423) is associated with an increased risk of torsades de pointes ventricular
tachycardia and sudden death. Common causes of a prolonged QT interval
include hypokalaemia, hypocalcaemia, hypomagnesaemia and some
medications.
The cardiac axis refers to the overall direction of the wave of ventricular
depolarization in the vertical plane measured from a zero reference point
(Fig. 10.6). The normal range for the cardiac axis is between −30° and
+90. An axis more negative than −30° is termed left axis deviation and an
U
P
0.04 s

406 Cardiovascular disease
(A)
AVR
–150°
(B)
+120°
Lead I
III
Right axis
deviation
Normal
axis
AVF
+90°
Left axis
deviation
Left axis
deviation
AVL
–30°
I 0°
Normal
axis
II
+60°
Right axis
deviation
Lead II
Lead III
Fig. 10.6 Cardiac vectors. (A) The hexaxial reference system, illustrating the
sixleads in the frontal plane, e.g. lead I is 0°, lead II is + 60°, lead III is 120°.
(B) ECG leads showing the predominant positive and negative deflection with
axis deviation.

The Electrocardiogram 407
axis more positive than +90° is termed right axis deviation. A simple
method to calculate the axis is by inspection of the QRS complex in leads I,
II and III. The axis is normal if leads I and II are positive; there is right axis
deviation if lead I is negative and lead III positive, and left axis deviation if
lead I is positive and leads II and III negative. Left axis deviation occurs due
to a block of the anterior bundle of the main left bundle conducting system
(seeFig. 10.2), inferior MI and the Wolff–Parkinson–White syndrome. Right
axis deviation may be normal and occurs in conditions in which there is right
ventricular overload, dextrocardia, Wolff–Parkinson–White syndrome and left
posterior hemiblock.
Exercise electrocardiography
Exercise electrocardiography assesses the cardiac response to exercise, but
is used less often than previously because of its low sensitivity.
24-hour ambulatory taped electrocardiography
A 12-lead ECG is recorded continuously over a 24-hour period and is used
to record transient changes such as a brief paroxysm of tachycardia, an
occasional pause in rhythm or intermittent ST segment shifts. It is also
called ‘Holter’ electrocardiography after its inventor. Event recording is used
to record less frequent arrhythmias in which the patient triggers an ECG
recording at the time of symptoms. They are both outpatient investigations.
A very small event recorder, known as an implantable loop recorder (ILR),
can also be implanted subcutaneously, triggered by events or a magnet, and
interrogated by the physician.
Tilt testing
Tilt testing is performed to investigate suspected neurocardiogenic (vasovagal) syncope in which patients give a history of repeated episodes of syncope
which occur without warning and are followed by a rapid recovery. The
patient lies on a swivel motorized table in a flat position with safety straps
applied across the chest and legs to hold them in position. Blood pressure,
heart rate, symptoms and an ECG are recorded after the table is tilted +60°
to the vertical for 10–60 minutes, thus simulating going from a flat to an
upright position. Reproduction of symptoms, bradycardia or hypotension
indicates a positive test. The overall sensitivity, specificity and reproducibility
are low.
Echocardiography
Echocardiography is an ultrasound examination of the heart (Fig. 10.7).
Different modalities (e.g. M mode, two- and three-dimensional) are used to

408 Cardiovascular disease
(B)
Recorder
Chest wall
(A)
LV
AMVL
PMVL
IVS
Aorta
LA
RVOT
Aorta
LA
RV
LV
MV
Ao
LA
Fig. 10.7 Echocardiogram: an example of a two-dimensional long-axis view.
(A) Diagram showing the anatomy of the area scanned and a diagrammatic
representation of the echocardiogram. (B) Two-dimensional long-axis view.
AMVL, anterior mitral valve leaflet; Ao, aorta; IVS, interventricular septum;
LA, left atrium; LV, left ventricle; MV, mitral valve; PMVL, posterior mitral valve
leaflet; RV, right ventricle; RVOT, right ventricular outflow tract.

The Electrocardiogram 409
provide information about cardiac structure and function. The examination is
performed in two ways:
• Transthoracic echo is the most common method and involves the
placement of a handheld transducer on the chest wall. Ultrasound
pulses are emitted through various body tissues, and reflected waves
are detected by the transducer as an echo. The most common reasons
for undertaking an echocardiogram are to assess ventricular function in
patients with symptoms suggestive of heart failure, or to assess valvular
disease. Left ventricular function is assessed by the ejection fraction
(percentage of blood ejected from the left ventricle with each heartbeat)
– normally >55%.
• Transoesophageal echo uses miniaturized transducers incorporated into
special endoscopes. It allows better visualization of some structures and
pathology, e.g. aortic dissection, endocarditis.
Further refinements of the echocardiogram are Doppler and stress
echocardiography. Doppler echocardiography uses the Doppler principle
(in this case, the frequency of ultrasonic waves reflected from blood cells
is related to their velocity and direction of flow) to identify and assess the
severity of valve lesions, estimate cardiac output and assess coronary blood
flow. Stress (exercise or pharmacological) echocardiography is used to
assess myocardial wall motion as a surrogate for coronary artery perfusion.
It is used in the detection of coronary artery disease, assessment of risk
post-MI and perioperatively, and in patients in whom routine exercise ECG
testing is non-diagnostic. For those who cannot exercise, pharmacological
intervention with dobutamine is used to increase myocardial oxygen demand.
Cardiac nuclear imaging
Cardiac nuclear imaging is used to detect MI or to measure myocardial function, perfusion or viability, depending on the radiopharmaceutical used and
the technique of imaging (either gamma camera or single-photon emission
computed tomography; SPECT). A variety of radiotracers can be injected
intravenously and these diffuse freely into myocardial tissue or attach to red
blood cells.
Thallium-201 is taken up by cardiac myocytes. Ischaemic areas (produced
by exercising the patient) with reduced tracer uptake are seen as ‘cold spots’
when imaged with a gamma camera.
Technetium-99 m is used to label red blood cells and produce images of
the left ventricle during systole and diastole.
Cardiac computed tomography
Computed tomography (CT) is useful for the assessment of the thoracic aorta
and mediastinum, and multidetector thin slice scanners can assess calcium
content of coronary arteries as an indicator of the presence and severity of

410 Cardiovascular disease
coronary artery stenoses. The current National Institute for Health and Care
Excellence (NICE) chest pain guidelines recommend the use of CT calcium
scoring in patients with chest pain and a 10%–29% likelihood of coronary
artery disease. CT coronary angiography (CTCA) has high sensitivity and
specificity for the detection of coronary artery diseases.
Cardiovascular magnetic resonance
Cardiovascular magnetic resonance (CMR) is a non-invasive imaging technique that does not involve harmful radiation. It is increasingly utilized in
the investigation of cardiovascular disease to provide both anatomical and
functional information. Contraindications are permanent pacemaker or defibrillator, intracerebral clips and significant claustrophobia. Coronary stents
and prosthetic valves are not a contraindication.
Positron emission tomography
Positron emission tomography (PET) has several advantages over other
techniques, such as improved spatial resolution, accurate quantification,
and use of biological isotopes of carbon, nitrogen and oxygen. However, it is
expensive and requires a cyclotron to produce the short-lived tracers. PET/
CT has become a useful investigation in the detection of viable myocardium
in patients who are suitable for revascularization.
Cardiac catheterization
A small catheter is passed through a peripheral vein (for study of right-sided
heart structures) or artery (for study of left-sided heart structures) into the
heart, permitting the securing of blood samples, measurement of intracardiac pressures and determination of cardiac anomalies. Specially designed
catheters are then used to selectively engage the left and right coronary
arteries, and contrast cine-angiograms are taken in order to define the
coronary circulation and identify the presence and severity of any coronary
artery disease. Coronary artery stenoses can be dilated (angioplasty) and
metal stents can be placed to reduce the rate of restenosis – this is referred
to as percutaneous coronary intervention (PCI). A further development is the
introduction of stents coated with drugs (sirolimus or paclitaxel) to reduce
cellular proliferation and restenosis rates still further. However, there is a risk
of late-stent thrombosis.
CARDIAC ARRHYTHMIAS
An abnormality of cardiac rhythm is called a cardiac arrhythmia. Arrhythmia
may cause sudden death, syncope, dizziness, palpitations or no symptoms

Cardiac Arrhythmias 411
at all. Twenty-four-hour ambulatory ECG monitoring and event recorders
(p. 407) are often used to detect paroxysmal arrhythmias.
There are two main types of arrhythmia:
• Bradycardia: the heart rate is slow (<60 beats/min). Slower heart rates
are more likely to cause symptomatic arrhythmias.
• Tachycardia: the heart rate is fast (>100 beats/min). Tachycardias
are more likely to be symptomatic when the arrhythmia is
fast andsustained. They are subdivided into supraventricular
tachycardias(SVTs), which arise from the atrium or the
atrioventricularjunction, and ventricular tachycardias, which arise
fromthe ventricles.
Arrhythmias and conduction disturbances complicating acute MI are
discussed on page 448.
General principles of management of arrhythmias
Patients with adverse symptoms and signs (low cardiac output, chest pain,
hypotension, impaired consciousness or severe pulmonary oedema) require
urgent treatment of their arrhythmia. Oxygen is given to all patients, intravenous access established and serum electrolyte abnormalities (potassium,
magnesium, calcium) are corrected.
Sinus rhythms
The normal cardiac pacemaker is the sinus node (Fig. 10.2) with the rate of
sinus node discharge under control of the autonomic nervous system with
parasympathetic predominating (resulting in slowing of the spontaneous
discharge rate).
Sinus arrhythmia
Fluctuations of autonomic tone result in phasic changes in the sinus
discharge rate. During inspiration, parasympathetic tone falls and the heart
rate quickens, and on expiration the heart rate falls. This variation is normal,
particularly in children and young adults, and typically results in predictable
irregularities of the pulse.
Bradycardias and heart block
Patients with persistent symptomatic bradycardia are treated with a
permanent cardiac pacemaker. First-line treatment in the acute situation with adverse signs is atropine (500 μg intravenously repeated to a
maximum of 3 mg, but contraindicated in myasthenia gravis and paralytic
ileus). Temporary pacing (transcutaneous, or transvenous if expertise
available) is an alternative.

412 Cardiovascular disease
Sinus bradycardia
Sinus bradycardia is normal during sleep and in well-trained athletes. Causes
are:
• Extrinsic to the heart: drug therapy (β-blockers, digitalis and other
antiarrhythmic drugs), hypothyroidism, hypothermia, cholestatic jaundice,
raised intracranial pressure. Treatment of symptomatic bradycardia is
that of the underlying cause.
• Intrinsic to the heart: acute ischaemia and infarction of the sinus node
(as a complication of MI) and chronic degenerative changes such as
fibrosis of the atrium and sinus node (sick sinus syndrome) occurring in
elderly people.
• Sick sinus syndrome. Bradycardia is caused by intermittent failure of
sinus node depolarization (sinus arrest) or failure of the sinus impulse
to propagate through the perinodal tissue to the atria (sinoatrial block).
The slow heart rate predisposes to ectopic pacemaker activity and
tachyarrhythmias are common (tachy–brady syndrome). The ECG
shows severe sinus bradycardia or intermittent long pauses between
consecutive P waves (>2 s, dropped P waves). Permanent pacemaker
insertion is indicated in symptomatic patients. Antiarrhythmic drugs
are used to treat tachycardias. Thromboembolism is common in sinus
node dysfunction and patients are anticoagulated unless there is a
contraindication.
Neurally mediated syndromes
These syndromes (e.g. carotid sinus syndrome (mainly elderly), vasovagal
attacks) are due to a reflex that may cause both bradycardia and reflex
peripheral vasodilatation, resulting in syncope or pre-syncope.
Heart block
The common causes of heart block are coronary artery disease, cardiomyopathy and, particularly in elderly people, fibrosis of the conducting tissue.
A block in either the AV node or the His bundle results in AV block, whereas
a block lower in the conduction system (see Fig. 10.2) produces right or left
bundle branch block.
Atrioventricular block
There are three forms:
First-degree AV block. This is the result of delayed atrioventricular
conduction and is reflected by a prolonged PR interval (>0.22 s) on the ECG.
No change in heart rate occurs and treatment is unnecessary.
Second-degree AV block. This occurs when some atrial impulses fail
to reach the ventricles.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
